(EXPE) Expedia - Overview
Stock: Flights, Hotels, Car Rentals, Vacation Packages
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.82% |
| Yield on Cost 5y | 1.11% |
| Yield CAGR 5y | % |
| Payout Consistency | 54.7% |
| Payout Ratio | 13.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 71.9% |
| Relative Tail Risk | -17.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 17.94 |
| Character TTM | |
|---|---|
| Beta | 1.537 |
| Beta Downside | 1.518 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.70% |
| CAGR/Max DD | 0.78 |
Description: EXPE Expedia December 17, 2025
Expedia Group, Inc. (NASDAQ: EXPE) is a global online travel platform that operates through three primary segments: B2C (consumer-facing brands such as Expedia, Hotels.com, Vrbo, Orbitz, Travelocity, and others), B2B (technology and distribution services for airlines, travel agents, corporate travel managers, and financial institutions), and trivago (hotel-metasearch referrals). The company monetizes its ecosystem via bookings, brand advertising, loyalty programs, and mobile/app-based engagements, and it has been publicly traded under its current name since 2018.
Key recent metrics: 2023 total revenue reached approximately $10.5 billion, with adjusted EBITDA margin around 13 %-both reflecting a rebound from pandemic lows but still below pre-COVID peaks. The B2C segment now contributes roughly 55 % of revenue, while B2B accounts for about 30 % and trivago the remaining 15 %. Macro-level drivers include robust leisure travel demand as discretionary spending recovers, persistent inflation pressure on discretionary travel budgets, and a continued shift toward alternative-accommodation bookings (Vrbo’s market share grew ~8 % YoY in 2023). The sector is also sensitive to airline capacity constraints and currency fluctuations, which can affect both pricing power and cost structure.
For a deeper quantitative view, you might explore ValueRay’s analyst platform.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 1.39b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 3.71 > 1.0 |
| NWC/Revenue: -30.70% < 20% (prev -29.53%; Δ -1.17% < -1%) |
| CFO/TA 0.15 > 3% & CFO 3.77b > Net Income 1.39b |
| Net Debt (-784.0m) to EBITDA (2.79b): -0.28 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (131.0m) vs 12m ago -3.48% < -2% |
| Gross Margin: 89.94% > 18% (prev 0.89%; Δ 8905 % > 0.5%) |
| Asset Turnover: 59.24% > 50% (prev 57.23%; Δ 2.01% > 0%) |
| Interest Coverage Ratio: 7.97 > 6 (EBITDA TTM 2.79b / Interest Expense TTM 240.0m) |
Altman Z'' -1.13
| A: -0.18 (Total Current Assets 12.85b - Total Current Liabilities 17.26b) / Total Assets 25.11b |
| B: 0.06 (Retained Earnings 1.54b / Total Assets 25.11b) |
| C: 0.08 (EBIT TTM 1.91b / Avg Total Assets 24.26b) |
| D: -0.67 (Book Value of Equity -15.11b / Total Liabilities 22.52b) |
| Altman-Z'' Score: -1.13 = CCC |
Beneish M -3.06
| DSRI: 1.10 (Receivables 4.52b/3.83b, Revenue 14.37b/13.39b) |
| GMI: 0.99 (GM 89.94% / 89.19%) |
| AQI: 0.90 (AQ_t 0.38 / AQ_t-1 0.42) |
| SGI: 1.07 (Revenue 14.37b / 13.39b) |
| TATA: -0.10 (NI 1.39b - CFO 3.77b) / TA 25.11b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of EXPE shares?
Over the past week, the price has changed by -11.02%, over one month by -17.74%, over three months by +11.66% and over the past year by +41.50%.
Is EXPE a buy, sell or hold?
- StrongBuy: 13
- Buy: 3
- Hold: 20
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the EXPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 288.4 | 21.9% |
| Analysts Target Price | 288.4 | 21.9% |
| ValueRay Target Price | 266.6 | 12.7% |
EXPE Fundamental Data Overview February 01, 2026
P/E Forward = 15.1515
P/S = 2.2801
P/B = 24.9986
P/EG = 0.7615
Revenue TTM = 14.37b USD
EBIT TTM = 1.91b USD
EBITDA TTM = 2.79b USD
Long Term Debt = 4.47b USD (from longTermDebt, last quarter)
Short Term Debt = 1.75b USD (from shortTermDebt, last quarter)
Debt = 6.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -784.0m USD (from netDebt column, last quarter)
Enterprise Value = 31.64b USD (32.76b + Debt 6.48b - CCE 7.61b)
Interest Coverage Ratio = 7.97 (Ebit TTM 1.91b / Interest Expense TTM 240.0m)
EV/FCF = 8.83x (Enterprise Value 31.64b / FCF TTM 3.58b)
FCF Yield = 11.33% (FCF TTM 3.58b / Enterprise Value 31.64b)
FCF Margin = 24.93% (FCF TTM 3.58b / Revenue TTM 14.37b)
Net Margin = 9.66% (Net Income TTM 1.39b / Revenue TTM 14.37b)
Gross Margin = 89.94% ((Revenue TTM 14.37b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 91.48% (prev 90.04%)
Tobins Q-Ratio = 1.26 (Enterprise Value 31.64b / Total Assets 25.11b)
Interest Expense / Debt = 0.96% (Interest Expense 62.0m / Debt 6.48b)
Taxrate = 14.77% (167.0m / 1.13b)
NOPAT = 1.63b (EBIT 1.91b * (1 - 14.77%))
Current Ratio = 0.74 (Total Current Assets 12.85b / Total Current Liabilities 17.26b)
Debt / Equity = 4.85 (Debt 6.48b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = -0.28 (Net Debt -784.0m / EBITDA 2.79b)
Debt / FCF = -0.22 (Net Debt -784.0m / FCF TTM 3.58b)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.72% (Net Income 1.39b / Total Assets 25.11b)
RoE = 115.6% (Net Income TTM 1.39b / Total Stockholder Equity 1.20b)
RoCE = 33.73% (EBIT 1.91b / Capital Employed (Equity 1.20b + L.T.Debt 4.47b))
RoIC = 21.94% (NOPAT 1.63b / Invested Capital 7.43b)
WACC = 9.80% (E(32.76b)/V(39.24b) * Re(11.58%) + D(6.48b)/V(39.24b) * Rd(0.96%) * (1-Tc(0.15)))
Discount Rate = 11.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.77%
[DCF Debug] Terminal Value 69.93% ; FCFF base≈3.14b ; Y1≈2.85b ; Y5≈2.48b
Fair Price DCF = 289.3 (EV 33.06b - Net Debt -784.0m = Equity 33.85b / Shares 117.0m; r=9.80% [WACC]; 5y FCF grow -11.62% → 2.90% )
EPS Correlation: 22.27 | EPS CAGR: 35.92% | SUE: -4.0 | # QB: 0
Revenue Correlation: 65.40 | Revenue CAGR: 19.26% | SUE: 2.59 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=15
EPS next Year (2026-12-31): EPS=17.96 | Chg30d=+0.135 | Revisions Net=+5 | Growth EPS=+18.1% | Growth Revenue=+7.4%